 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. Centers for Disease Control and Prevention
• U.S. News
Pennsylvania Public Welfare Expands Drug Benefits for HIV PatientsNovember 17, 2003 Pennsylvania Public Welfare Secretary Estelle Richman recently announced the addition of Emtriva (emtricitabine) and Reyataz (atazanavir sulfate) for the treatment of HIV/AIDS to the Special Pharmaceutical Benefits Program (SPBP). The program now offers 72 different types of drugs and treatments for its 5,000 HIV/AIDS patients. The pills are taken once daily, reducing the pill burden often associated with combination therapy. To be eligible for SPBP, non-institutionalized Pennsylvania residents must have a medical need and an individual gross income of less than $30,000, with an additional allowance of $2,480 for each additional family member.
Adapted from:Back to other news for November 17, 2003 AIDS Weekly 11.10.03 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
E-Mail
Printable Single-Page
Glossary
Share
